Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

GC Corp. — Artiva Biotherapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / GC Corp.

GC Corp.

10% owner at Artiva Biotherapeutics, Inc. · on record since May 28, 2026

Insider trading activity of GC Corp.

Transactions on record: 2; since May 28, 2026

Open-market buys: 2; $16.5M

Open-market sells: 0

Companies traded: 1; last filing May 28, 2026

Figures computed from official regulatory filings — methodology.

Companies where GC Corp. has traded

Artiva Biotherapeutics, Inc.2 tx · $16.5M · May 28, 2026

Track record of GC Corp.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of GC Corp.

Co-insiders of GC Corp.

5AM Opportunities II (GP), LLCArtiva Biotherapeutics, Inc.
5AM Opportunities II, L.P.Artiva Biotherapeutics, Inc.
5AM Partners VI, LLCArtiva Biotherapeutics, Inc.
5AM Ventures VI, L.P.Artiva Biotherapeutics, Inc.
Adelman Robert JArtiva Biotherapeutics, Inc.
Aslan FredArtiva Biotherapeutics, Inc.
Baker Daniel G.Artiva Biotherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Banerjee SubhashisArtiva Biotherapeutics, Inc.

Bessen LauraArtiva Biotherapeutics, Inc.

Bush JenniferArtiva Biotherapeutics, Inc.

DANIELS BRIANArtiva Biotherapeutics, Inc.

GC Cell CorpArtiva Biotherapeutics, Inc.

GOODMAN COREY SArtiva Biotherapeutics, Inc.

Graef ThorstenArtiva Biotherapeutics, Inc.

Horan ChristopherArtiva Biotherapeutics, Inc.

HOUGEN ELIZABETH LArtiva Biotherapeutics, Inc.

Huh Yong-JunArtiva Biotherapeutics, Inc.

Huston Thad AllenArtiva Biotherapeutics, Inc.

Kolchinsky PeterArtiva Biotherapeutics, Inc.

Krishnamohan NehaArtiva Biotherapeutics, Inc.

Miralles Gines DiegoArtiva Biotherapeutics, Inc.

MOORE ALISONArtiva Biotherapeutics, Inc.

PARMAR KUSHArtiva Biotherapeutics, Inc.

RA Capital Biotech Fund LPArtiva Biotherapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCArtiva Biotherapeutics, Inc.

RA Capital Nexus Fund III, L.P.Artiva Biotherapeutics, Inc.

RA Capital Nexus Fund, L.P.Artiva Biotherapeutics, Inc.

Raymon HeatherArtiva Biotherapeutics, Inc.

Schwab Andrew J.Artiva Biotherapeutics, Inc.

Shah Rajeev M.Artiva Biotherapeutics, Inc.

Sorg Elaine K.Artiva Biotherapeutics, Inc.

Stoppel LauraArtiva Biotherapeutics, Inc.

venBio Global Strategic Fund III, L.P.Artiva Biotherapeutics, Inc.

VENBIO GLOBAL STRATEGIC GP III, L.P.Artiva Biotherapeutics, Inc.

VENBIO GLOBAL STRATEGIC GP III, LTDArtiva Biotherapeutics, Inc.

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Artiva Biotherapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Artiva Biotherapeutics, Inc.	May 28, 2026	Buy	347,222	11.52 USD	$4M	SEC
Artiva Biotherapeutics, Inc.	May 28, 2026	Buy	1,085,069	11.52 USD	$12.5M	SEC